HCPLive Network

Accelerated Cognitive Decline Seen With Type 2 Diabetes in Middle Age

 
MONDAY, Jan. 21 (HealthDay News) -- Middle-aged patients with type 2 diabetes show accelerated cognitive decline in information processing speed and executive function, according to a study published online Dec. 28 in Diabetes Care.

To examine the effects of baseline and incident diabetes on cognitive function, Peggy J.J. Spauwen, from Maastricht University in the Netherlands, and colleagues conducted cognitive testing on 1,290 individuals (40 years or older) participating in the Maastricht Aging Study. Testing was performed at baseline and at six and 12 years.

At baseline, 68 participants had type 2 diabetes, while 54 and 57 had incident diabetes at the six- and 12-year follow-up, respectively. Over the 12-year follow-up, the researchers identified significantly larger decline in information-processing speed, executive function, and delayed word recall among those with diabetes at baseline, compared with control subjects. There was no significant difference noted in the decline for immediate word recall. Participants with incident diabetes showed subtle early decrease in information-processing speed only, compared to the controls; however, in other cognitive domains there was no larger decline observed.

"It seems that disease-exposure time plays an important role in the development of cognitive decline. This might provide a window of opportunity for prevention and early treatment of diabetes-related cognitive deficits," the authors write. "For this, it is important to assess cognitive status at an early stage of the disease and on a regular basis."
 

Abstract
Full Text (subscription or payment may be required)


Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
In the February issue of MD Magazine, our cover story takes a look at the growing world of so-called "concierge medicine." In this preview video, Princeton, NJ internist Simon D. Murray, MD, discusses how switching to a retainer-based model of care has affected his workflow.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah recently discovered the mechanism potentially triggering pancreatic cancer from the defects resulting from extrusion, the process through which cells are squeezed out of overcrowded tissue to die.
Major depressive episodes (MDEs) have physical symptoms such as anhedonia, anorexia and weight loss—all of which can be triggered by activation of the immune system.In a report in JAMA Psychiatry Elaine Setiawan, PhD and colleagues said their research shows that translocator protein density intensifies during an MDE, and that shows brain inflammation.They measured translocator protein by distribution volume (TSPOVt) assessed through PET scans.
More Reading